Document is current
Any future updates will be listed below
-
Authors
Meier, Daniel T.
de Paula Souza, Joyce
Donath, Marc Y.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (# 320030_214900, # 32003B_212319)
University of Basel
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 30 September 2024
First Online: 4 November 2024
Funding
: Open access funding provided by University of Basel. Work in the authors’ laboratories is supported by the Swiss National Science Foundation (214900 and 212319) and the European Union – Horizon/Swiss State Secretariat for Education, Research and Innovation (101095433).
: Olatec provides the authors with an NLRP3 inhibitor used for an ongoing clinical study funded by a European Union/Swiss grant.
: All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.
